Cancer-linked aggregation of p53 is driven by sequence-encoded frustration, solvation, and hydrophobic gating absent in its paralogs
Open Access
- 16 May 2026
- journal article
- Published by Springer Nature in Communications Chemistry
- Vol. 9 (1)
Abstract
Tumor suppressor p53 is uniquely prone to misfolding and aggregation, a property tightly linked to oncogenic mutations and absent in its paralogs, p63 and p73. Yet, the biophysical origins underlying divergent aggregation propensity remain incompletely understood. Here, we integrate fluorescence spectroscopy, high-pressure and chemical denaturation NMR, molecular dynamics simulations, and energetic frustration analysis to dissect the structural and dynamic discrepancies among p53 and its paralogs. Our results reveal that p53 harbors distinct surface-exposed solvation patches and cavity-prone regions promoting local conformational plasticity. Residue-level NMR analysis uncovers a broad, asymmetric distribution of signal intensity changes with pressure, correlating with discrete solvation patches and frustration-prone regions. These features coincide with highly frustrated contact networks and altered hydrophobic core gating, collectively facilitating aggregation-prone states. In contrast, p63 and p73 exhibit more uniform solvation, reduced frustration, and tighter core packing, conferring greater structural stability. These mechanistic differences directly link uneven hydration and compressibility to the heightened amyloid aggregation propensity of p53C. These contrasting energetic landscapes illustrate how evolutionary sequence divergence fine-tunes p53 for functional flexibility at the expense of stability, predisposing it to pathological aggregation. Our findings illuminate the structural determinants that distinguish pathological folding in p53 and may guide therapeutic stabilization strategies.Keywords
This publication has 74 references indexed in Scilit:
- Advancement in SARS-CoV-2 diagnosis: A new and stable electrochemical biosensor for genomic RNA detectionBioelectrochemistry, 2024
- Nuclear inclusion bodies of mutant and wild‐type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregationThe Journal of Pathology, 2016
- A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian CarcinomasCancer Cell, 2016
- Backbone resonance assignments of the human p73 DNA binding domainBiomolecular NMR Assignments, 2015
- Clinical significance of different types of p53 gene alteration in surgically treated prostate cancerInternational Journal of Cancer, 2014
- Co-localization of mutant p53 and amyloid-like protein aggregates in breast tumorsThe International Journal of Biochemistry & Cell Biology, 2011
- CHARMM‐GUI: A web‐based graphical user interface for CHARMMJournal of Computational Chemistry, 2008
- Conformational fluctuations of proteins revealed by variable pressure NMRBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2006
- The CCPN data model for NMR spectroscopy: Development of a software pipelineProteins: Structure, Function, and Bioinformatics, 2005
- The fluorescence decay of tryptophan residues in native and denatured proteinsBiochimica et Biophysica Acta (BBA) - Protein Structure, 1976